01.19.16
The Food and Drug Administration (FDA) has issued a letter of no objection regarding the Generally Recognized As Safe (GRAS) status of Brassica Protection Products’ truebroc brand of glucoraphanin in food applications.
Brassica’s truebroc from broccoli is the first source of glucoraphanin to receive this status, the company said.
“The successful review of our GRAS dossier for truebroc reaffirms all of the time, extensive research and testing we dedicate to demonstrating the product’s safety,” said Tony Talalay, CEO of Brassica Protection Products. “Notably, the GRAS dossier featured a complete review of the safety of our water-extraction production process from field to finished product. We look forward to promoting the health benefits and safety profile of truebroc to food, beverage and supplement manufacturers who want to add glucoraphanin to their consumer products.”
In 2013, an independent panel of experts concluded that Brassica’s truebroc was GRAS for use in food applications. In December 2013, Brassica submitted its GRAS Notification to the FDA with guidance from Spherix Consulting, a division of ChromaDex.
“The independent expert panel we convened in 2013 carefully reviewed and evaluated the publicly available information about glucoraphanin from broccoli seeds and determined that it is generally recognized to be safe for ingestion at the proposed levels of use,” commented Claire Kruger, PhD, DABT, president of Spherix Consulting, Inc. “The successful GRAS Notification adds another level of transparency to the scientific process—reassuring consumers that Brassica’s truebroc is safe.”
Brassica’s truebroc from broccoli is the first source of glucoraphanin to receive this status, the company said.
“The successful review of our GRAS dossier for truebroc reaffirms all of the time, extensive research and testing we dedicate to demonstrating the product’s safety,” said Tony Talalay, CEO of Brassica Protection Products. “Notably, the GRAS dossier featured a complete review of the safety of our water-extraction production process from field to finished product. We look forward to promoting the health benefits and safety profile of truebroc to food, beverage and supplement manufacturers who want to add glucoraphanin to their consumer products.”
In 2013, an independent panel of experts concluded that Brassica’s truebroc was GRAS for use in food applications. In December 2013, Brassica submitted its GRAS Notification to the FDA with guidance from Spherix Consulting, a division of ChromaDex.
“The independent expert panel we convened in 2013 carefully reviewed and evaluated the publicly available information about glucoraphanin from broccoli seeds and determined that it is generally recognized to be safe for ingestion at the proposed levels of use,” commented Claire Kruger, PhD, DABT, president of Spherix Consulting, Inc. “The successful GRAS Notification adds another level of transparency to the scientific process—reassuring consumers that Brassica’s truebroc is safe.”
